XML 90 R81.htm IDEA: XBRL DOCUMENT v3.23.3
Supplemental Consolidating Data - Cash Flows (Details) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2023
Jun. 30, 2023
Mar. 31, 2023
Sep. 25, 2022
Jun. 26, 2022
Mar. 27, 2022
Sep. 30, 2023
Sep. 25, 2022
Cash flows from operating activities:                
Net income $ 196,103 $ 173,830 $ 301,829 $ 261,186 $ 215,849 $ 222,502 $ 671,762 $ 699,537
Adjustments to reconcile Net income to Net cash provided by operating activities:                
Depreciation and amortization             112,592 114,867
Amortization of deferred loan origination costs             65,996 72,214
Amortization of financing origination fees             9,734 11,475
Provision for long-term employee benefits             (50,373) (14,637)
Employee benefit plan contributions and payments             (2,668) (4,766)
Stock compensation expense             64,538 33,595
Net change in wholesale finance receivables related to sales             (392,817) (294,698)
Provision for credit losses             170,496 94,572
Deferred income taxes             (8,455) (2,980)
Other, net             (19,738) 24,392
Changes in current assets and liabilities:                
Accounts receivable, net             (72,084) (150,726)
Finance receivables – accrued interest and other             2,366 3,566
Inventories, net             160,742 (6,577)
Accounts payable and accrued liabilities             14,453 37,745
Other current assets             (19,777) (42,875)
Total adjustments             35,005 (124,833)
Net cash provided by operating activities             706,767 574,704
Cash flows from investing activities:                
Capital expenditures             (138,902) (84,947)
Origination of finance receivables             (3,162,957) (3,773,830)
Collections on finance receivables             2,789,848 3,110,881
Other investing activities             878 2,160
Net cash used by investing activities             (511,133) (745,736)
Cash flows from financing activities:                
Proceeds from issuance of medium-term notes             1,446,304 495,785
Repayments of medium-term notes             (1,056,680) (950,000)
Proceeds from securitization debt             1,045,547 1,826,891
Repayments of securitization debt             (930,608) (1,054,939)
Borrowings of asset-backed commercial paper             42,429 448,255
Repayments of asset-backed commercial paper             (187,599) (228,431)
Net increase (decrease) in unsecured commercial paper             43,523 (60,281)
Net increase in deposits             161,157 54,080
Deposit in advance of business combination               100,000
Dividends paid             (72,775) (70,163)
Repurchase of common stock             (239,428) (338,496)
Other financing activities             1,706 (1,237)
Net cash provided by financing activities             253,576 221,464
Effect of exchange rate changes on cash, cash equivalents and restricted cash             (8,415) (33,361)
Cash, cash equivalents and restricted cash:                
Cash, cash equivalents and restricted cash, beginning of period     1,579,177     2,025,219 1,579,177 2,025,219
Net (decrease) increase in cash, cash equivalents and restricted cash             440,795 17,071
Cash, cash equivalents and restricted cash, end of period 2,019,972     2,042,290     2,019,972 2,042,290
Reportable Legal Entities | Non-Financial Services Entities                
Cash flows from operating activities:                
Net income 352,629     401,651     739,888 712,620
Adjustments to reconcile Net income to Net cash provided by operating activities:                
Depreciation and amortization             105,824 108,485
Amortization of deferred loan origination costs             0 0
Amortization of financing origination fees             532 524
Provision for long-term employee benefits             (50,373) (14,637)
Employee benefit plan contributions and payments             (2,668) (4,766)
Stock compensation expense             61,642 31,418
Net change in wholesale finance receivables related to sales             0 0
Provision for credit losses             0 0
Deferred income taxes             147 1,981
Other, net             (15,606) 20,190
Changes in current assets and liabilities:                
Accounts receivable, net             (312,549) (443,645)
Finance receivables – accrued interest and other             0 0
Inventories, net             160,742 (6,577)
Accounts payable and accrued liabilities             (10,440) 22,075
Other current assets             (24,418) (58,774)
Total adjustments             (87,167) (343,726)
Net cash provided by operating activities             652,721 368,894
Cash flows from investing activities:                
Capital expenditures             (135,768) (82,153)
Origination of finance receivables             0 0
Collections on finance receivables             0 0
Other investing activities             (1,622) 2,160
Net cash used by investing activities             (137,390) (79,993)
Cash flows from financing activities:                
Proceeds from issuance of medium-term notes             0 0
Repayments of medium-term notes             0 0
Proceeds from securitization debt             0 0
Repayments of securitization debt             0 0
Borrowings of asset-backed commercial paper             0 0
Repayments of asset-backed commercial paper             0 0
Net increase (decrease) in unsecured commercial paper             0 0
Net increase in deposits             0 0
Deposit in advance of business combination               100,000
Dividends paid             (72,775) (70,163)
Repurchase of common stock             (239,428) (338,496)
Other financing activities             1,706 (1,237)
Net cash provided by financing activities             (310,497) (309,896)
Effect of exchange rate changes on cash, cash equivalents and restricted cash             (8,212) (30,821)
Cash, cash equivalents and restricted cash:                
Cash, cash equivalents and restricted cash, beginning of period     1,021,798     1,078,205 1,021,798 1,078,205
Net (decrease) increase in cash, cash equivalents and restricted cash             196,622 (51,816)
Cash, cash equivalents and restricted cash, end of period 1,218,420     1,026,389     1,218,420 1,026,389
Reportable Legal Entities | Financial Services Entities                
Cash flows from operating activities:                
Net income 43,523     59,413     131,842 186,800
Adjustments to reconcile Net income to Net cash provided by operating activities:                
Depreciation and amortization             6,768 6,382
Amortization of deferred loan origination costs             65,996 72,214
Amortization of financing origination fees             9,202 10,951
Provision for long-term employee benefits             0 0
Employee benefit plan contributions and payments             0 0
Stock compensation expense             2,896 2,177
Net change in wholesale finance receivables related to sales             0 0
Provision for credit losses             170,496 94,572
Deferred income taxes             (8,764) (4,681)
Other, net             (4,099) 4,318
Changes in current assets and liabilities:                
Accounts receivable, net             0 0
Finance receivables – accrued interest and other             2,366 3,566
Inventories, net             0 0
Accounts payable and accrued liabilities             257,748 321,594
Other current assets             4,645 2,615
Total adjustments             507,254 513,708
Net cash provided by operating activities             639,096 700,508
Cash flows from investing activities:                
Capital expenditures             (3,134) (2,794)
Origination of finance receivables             (6,035,046) (6,642,296)
Collections on finance receivables             5,276,887 5,684,649
Other investing activities             0 0
Net cash used by investing activities             (761,293) (960,441)
Cash flows from financing activities:                
Proceeds from issuance of medium-term notes             1,446,304 495,785
Repayments of medium-term notes             (1,056,680) (950,000)
Proceeds from securitization debt             1,045,547 1,826,891
Repayments of securitization debt             (930,608) (1,054,939)
Borrowings of asset-backed commercial paper             42,429 448,255
Repayments of asset-backed commercial paper             (187,599) (228,431)
Net increase (decrease) in unsecured commercial paper             43,523 (60,281)
Net increase in deposits             161,157 54,080
Deposit in advance of business combination               0
Dividends paid             (200,000) (200,000)
Repurchase of common stock             0 0
Other financing activities             2,500 0
Net cash provided by financing activities             366,573 331,360
Effect of exchange rate changes on cash, cash equivalents and restricted cash             (203) (2,540)
Cash, cash equivalents and restricted cash:                
Cash, cash equivalents and restricted cash, beginning of period     557,379     947,014 557,379 947,014
Net (decrease) increase in cash, cash equivalents and restricted cash             244,173 68,887
Cash, cash equivalents and restricted cash, end of period 801,552     1,015,901     801,552 1,015,901
Consolidating Adjustments                
Cash flows from operating activities:                
Net income (200,049)     (199,878)     (199,968) (199,883)
Adjustments to reconcile Net income to Net cash provided by operating activities:                
Depreciation and amortization             0 0
Amortization of deferred loan origination costs             0 0
Amortization of financing origination fees             0 0
Provision for long-term employee benefits             0 0
Employee benefit plan contributions and payments             0 0
Stock compensation expense             0 0
Net change in wholesale finance receivables related to sales             (392,817) (294,698)
Provision for credit losses             0 0
Deferred income taxes             162 (280)
Other, net             (33) (116)
Changes in current assets and liabilities:                
Accounts receivable, net             240,465 292,919
Finance receivables – accrued interest and other             0 0
Inventories, net             0 0
Accounts payable and accrued liabilities             (232,855) (305,924)
Other current assets             (4) 13,284
Total adjustments             (385,082) (294,815)
Net cash provided by operating activities             (585,050) (494,698)
Cash flows from investing activities:                
Capital expenditures             0 0
Origination of finance receivables             2,872,089 2,868,466
Collections on finance receivables             (2,487,039) (2,573,768)
Other investing activities             2,500 0
Net cash used by investing activities             387,550 294,698
Cash flows from financing activities:                
Proceeds from issuance of medium-term notes             0 0
Repayments of medium-term notes             0 0
Proceeds from securitization debt             0 0
Repayments of securitization debt             0 0
Borrowings of asset-backed commercial paper             0 0
Repayments of asset-backed commercial paper             0 0
Net increase (decrease) in unsecured commercial paper             0 0
Net increase in deposits             0 0
Deposit in advance of business combination               0
Dividends paid             200,000 200,000
Repurchase of common stock             0 0
Other financing activities             (2,500) 0
Net cash provided by financing activities             197,500 200,000
Effect of exchange rate changes on cash, cash equivalents and restricted cash             0 0
Cash, cash equivalents and restricted cash:                
Cash, cash equivalents and restricted cash, beginning of period     $ 0     $ 0 0 0
Net (decrease) increase in cash, cash equivalents and restricted cash             0 0
Cash, cash equivalents and restricted cash, end of period $ 0     $ 0     $ 0 $ 0